Evotec
Cathy Morgado is an EHS Specialist at Evotec since February 2021, with prior experience as an EHS Advisor during a six-month secondment and as a Research Associate in Medicinal Chemistry. Previous roles include an Export Account Manager at Servier Pharmaceuticals and research internships in therapeutic chemistry at CHANEL and CEISAM, focusing on the synthesis of therapeutic compounds. Educational background includes a Master's Degree and Bachelor's Degree in Therapeutic Chemistry, along with a Two-Year Technical Degree in Chemistry, all obtained from Nantes Université and Ecole Technique Supérieure de Chimie de l'Ouest. Cathy has been recognized with the 2nd Best Trainee Presentation prize and has contributed to published research in antifungal activity.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.